Evaluation of the current management protocols for prophylaxis against Pneumocystis jiroveci pneumonia and other opportunistic infections in patients living with HIV/AIDS

被引:5
|
作者
Jain, Sheel Bhadra [1 ]
Wig, Naveet [1 ]
Nagpal, Sajan Jiv Singh [1 ]
Mishra, Nitin [1 ]
Vajpayee, Madhu [1 ]
Guleria, Randeep [1 ]
Pandey, Ravindra Mohan [1 ]
Sharma, Surendra K. [1 ]
机构
[1] All India Inst Med Sci, Dept Med, New Delhi 110029, India
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2011年 / 23卷 / 07期
关键词
HIV; prophylaxis; management; India; Pneumocystis carinii; ACTIVE ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-AVIUM COMPLEX; HEPATITIS-C COINFECTION; CARINII-PNEUMONIA; HIV-INFECTION; NORTH-INDIA; VIRUS; ERA;
D O I
10.1080/09540121.2010.542129
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Opportunistic infections (OIs) are a leading cause of mortality and morbidity in patients living with HIV/AIDS. Data on the proper administration of prophylactic regimes for the prevention of OIs in such patients are scarce. A total of 205 confirmed HIV-infected patients were enrolled in the study from the inpatient wards and outpatient services. The treatment given to them for the prevention of Pneumocystis carinii (jiroveci) pneumonia was compared with the established guidelines and the proportions of those receiving proper treatment were calculated. Primary prophylaxis was seen to be satisfactory in the case of P. carinii (jiroveci) pneumonia. The prophylaxis was not given properly for tuberculosis and other common OIs. Secondary prophylaxis was up to the mark. Prophylaxis in AIDS patients seems to be a major problem area and a lot of efforts need to be directed toward it since patients suffering from AIDS are bound to have a downhill course despite provision of all available treatment options.
引用
收藏
页码:846 / 850
页数:5
相关论文
共 16 条
  • [1] Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city:: A persistent and deadly opportunistic infection
    Tellez, Ildefonso
    Barragan, Maribel
    Franco-Paredes, Carlos
    Petraro, Paul
    Nelson, Kenrad
    Del Rio, Carlos
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 335 (03): : 192 - 197
  • [2] CURRENT STATUS OF PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN HIV-INFECTED PATIENTS
    DECKER, CF
    MASUR, H
    AIDS, 1994, 8 (01) : 11 - 20
  • [3] Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease
    Okafor, Philip N.
    Farraye, Francis A.
    Okafor, Adetoro T.
    Erim, Daniel O.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (12) : 3743 - 3755
  • [4] Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?
    Liebling, Maryjane
    Rubio, Edmundo
    Ie, Susanti
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (02) : 171 - 181
  • [5] Fact or Fiction: Does the Non-HIV/AIDS Immunosuppressed Patient Need Pneumocystis jiroveci Pneumonia Prophylaxis? An Updated Literature Review
    Grewal, Parbeer
    Brassard, Alain
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 (06) : 308 - 312
  • [6] How successful are we in administering prophylaxis against Pneumocystis carinii pneumonia (PCP) in patients with HIV infection
    Knowles, C
    EastInnis, A
    Bradbeer, CS
    Bateman, NT
    INTERNATIONAL JOURNAL OF STD & AIDS, 1997, 8 (05) : 345 - 346
  • [7] THE USE OF INTRAVENOUS PENTAMIDINE AS PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH HIV-INFECTION
    SCHROEDER, KE
    BARTON, SE
    INTERNATIONAL JOURNAL OF STD & AIDS, 1994, 5 (05) : 353 - 355
  • [8] Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/OAG) (AWMF 055/066)
    Thoden, J.
    Potthoff, A.
    Bogner, J. R.
    Brockmeyer, N. H.
    Esser, S.
    Grabmeier-Pfistershammer, K.
    Haas, B.
    Hahn, K.
    Haerter, G.
    Hartmann, M.
    Herzmann, C.
    Hutterer, J.
    Jordan, A. R.
    Lange, C.
    Mauss, S.
    Meyer-Olson, D.
    Mosthaf, F.
    Oette, M.
    Reuter, S.
    Rieger, A.
    Rosenkranz, T.
    Ruhnke, M.
    Schaaf, B.
    Schwarze, S.
    Stellbrink, H. J.
    Stocker, H.
    Stoehr, A.
    Stoll, M.
    Traeder, C.
    Vogel, M.
    Wagner, D.
    Wyen, C.
    Hoffmann, C.
    INFECTION, 2013, 41 : S91 - S115
  • [9] INCIDENCE OF SYMPTOMATIC URINARY-TRACT INFECTIONS IN HIV-SEROPOSITIVE PATIENTS AND THE USE OF COTRIMOXAZOLE AS PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA
    EVANS, JK
    MCOWAN, A
    HILLMAN, RJ
    FORSTER, GE
    GENITOURINARY MEDICINE, 1995, 71 (02): : 120 - 122
  • [10] Is It Safe to Discontinue Primary Pneumocystis jiroveci Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count <200 Cells/μL?
    Furrer, Hansjakob
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (05) : 611 - 619